resveratrol has been researched along with Bladder Cancer in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (80.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, TC; da Silva, GN; de Medeiros Teixeira, LF; Lima, APB; Melo, AS; Soares, LBM | 1 |
| Hong, CT; Liu, PY; Liu, YW; Shen, CH; Wang, CH; Wang, SC; Wu, JY; Wu, SR | 1 |
| Biagini, A; Caglioti, C; Claps, F; Fioretti, B; Gentile, R; Palazzetti, F; Pastore, AL; Perotti, A; Sallicandro, L; Zucchi, A | 1 |
| Almeida, TC; da Silva, GN; De Assis, BLG; de Oliveira Aguiar Soares, RD; Garcia, CCM; Guerra, CCC; Lima, AA | 1 |
| Hadjipavlou, M; Khan, S; Philippou, Y; Rane, A | 1 |
| Ding, J; Wu, Y; Zhou, C | 1 |
| Chen, XY; Kong, QY; Li, H; Liu, J; Shu, XH; Song, X; Wu, ML; Yu, LJ | 1 |
| Alayev, A; Berman, AY; Holz, MK; Salamon, RS; Schwartz, NS; Wiener, SL | 1 |
| Bai, Y; Hu, L; Lei, Y; Li, R; Mao, Q; Qin, Y; Wang, Q; Yang, H; Yang, Y; Zhang, G | 1 |
| Meng, Q; Wang, S; Xie, Q; Zhang, M | 1 |
| Deng, S; Diao, Y; Li, C; Li, H; Liu, J; Ma, X; Ren, C; Shu, X; Wu, M; Yang, Y; Zhen, Y | 1 |
| Bai, Y; Mao, QQ; Qin, J; Shen, HF; Wang, YB; Xie, LP; Yang, K; Zheng, XY | 1 |
| Grubbs, CJ; Juliana, MM; Lubet, RA; Steele, VE | 1 |
| Koyama, N; Paulo, M; Salvador, M; Stocco, B; Toledo, K; Torqueti Toloi, MR | 1 |
| Huo, WQ; Jin, FS; Lin, X; Wu, G; Zhang, Y | 1 |
2 review(s) available for resveratrol and Bladder Cancer
| Article | Year |
|---|---|
Focus on the Use of Resveratrol in Bladder Cancer.
Topics: Administration, Intravesical; Combined Modality Therapy; Humans; Male; Resveratrol; Urinary Bladder Neoplasms | 2023 |
Complementary and alternative medicine (CAM) in prostate and bladder cancer.
Topics: Acupuncture; Antineoplastic Agents; Antioxidants; Camellia sinensis; Complementary Therapies; Drugs, Chinese Herbal; Female; Humans; Male; Plant Extracts; Prostatic Neoplasms; Resveratrol; Selenium; Silybin; Silymarin; Stilbenes; Urinary Bladder Neoplasms; Vitamin E; Vitamins | 2013 |
13 other study(ies) available for resveratrol and Bladder Cancer
| Article | Year |
|---|---|
Additive effects of resveratrol and doxorubicin on bladder cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Humans; Oxidative Stress; Resveratrol; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2022 |
The suppressive role of phytochemical-induced glutathione S-transferase Mu 2 in human urothelial carcinoma cells.
Topics: Carcinoma, Transitional Cell; DNA Methylation; Glutathione Transferase; Humans; Phytochemicals; Resveratrol; Sp1 Transcription Factor; Urinary Bladder Neoplasms | 2022 |
Antiproliferative and toxicogenomic effects of resveratrol in bladder cancer cells with different TP53 status.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; DNA Damage; Humans; Polo-Like Kinase 1; Proliferating Cell Nuclear Antigen; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Resveratrol; S Phase Cell Cycle Checkpoints; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms | 2019 |
Resveratrol induces apoptosis of bladder cancer cells via miR‑21 regulation of the Akt/Bcl‑2 signaling pathway.
Topics: Apoptosis; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Signal Transduction; Stilbenes; Urinary Bladder Neoplasms | 2014 |
Short-term resveratrol exposure causes in vitro and in vivo growth inhibition and apoptosis of bladder cancer cells.
Topics: Active Transport, Cell Nucleus; Analysis of Variance; Animals; Apoptosis; Blotting, Western; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; DNA Primers; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Mice; Mice, Nude; Phosphorylation; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; S Phase Cell Cycle Checkpoints; STAT3 Transcription Factor; Stilbenes; Tyrphostins; Urinary Bladder Neoplasms | 2014 |
Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line; Cell Movement; Cell Proliferation; Embryo, Mammalian; Enzyme Activation; Fibroblasts; Humans; Mechanistic Target of Rapamycin Complex 1; Mice; Multiprotein Complexes; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins; Urinary Bladder Neoplasms | 2017 |
Inhibitory effects of resveratrol on the adhesion, migration and invasion of human bladder cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Phosphorylation; Resveratrol; Stilbenes; Urinary Bladder; Urinary Bladder Neoplasms | 2017 |
Effect and mechanism of resveratrol on drug resistance in human bladder cancer cells.
Topics: Antineoplastic Agents; Biomarkers; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Resveratrol; RNA, Messenger; Stilbenes; Urinary Bladder Neoplasms | 2017 |
Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arylsulfotransferase; Cell Line, Tumor; Cell Proliferation; Humans; Rats; Resveratrol; Stilbenes; Urinary Bladder Neoplasms | 2017 |
Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; G1 Phase; Humans; Male; Mice; Mice, Inbred BALB C; p38 Mitogen-Activated Protein Kinases; Resveratrol; Stilbenes; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2010 |
Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Gefitinib; Naproxen; Quinazolines; Rats; Rats, Inbred F344; Research Design; Resveratrol; Stilbenes; Urinary Bladder Neoplasms | 2010 |
Dose-dependent effect of resveratrol on bladder cancer cells: chemoprevention and oxidative stress.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-Associated Death Protein; Cell Line, Tumor; Dinoprostone; Dose-Response Relationship, Drug; Humans; Neutrophils; Nitric Oxide; Oxidative Stress; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Tetradecanoylphorbol Acetate; Urinary Bladder Neoplasms | 2012 |
Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Membrane Potential, Mitochondrial; Mice; Reactive Oxygen Species; Resveratrol; Stilbenes; Urinary Bladder Neoplasms | 2012 |